If you’re looking to buy a marijuana stock, Aphria (NYSE:APHA) and Canopy Growth (NYSE:CGC) should probably be on your list for consideration. They’re two of the largest Canadian cannabis producers in terms of production capacity. Both Aphria and Canopy Growth…
No industry is as hot as the marijuana industry right now. Within the U.S. alone, sales of state-regulated cannabis will grow to more than $22 billion by 2022, according to the Arcview Group, up from $8.6 billion in 2017. And this…
The marijuana industry is a lot of things. It’s a potentially once-in-a-generation growth opportunity for investors, with up to $75 billion in full-year sales expected by the time 2030 rolls around. This rapid sales growth is a big reason more…
Marijuana isn’t just another growth industry. It has the potential to be a once-in-a-generation growth opportunity for patient investors who have a keen eye for this fast-paced industry. Between 2018 and 2030, various Wall Street firms have called for a…
Last year, cannabis stocks entered the mainstream, thanks to the legalization of recreational marijuana in Canada and the increasing momentum of the legalization movement in the United States. Investor interest in this space remains in high gear, driven by strong performances…
If you’re considering buying either Canopy Growth (NYSE:CGC) or Scotts Miracle-Gro (NYSE:SMG), you probably wish you could turn back the hands of time. Both stocks are up more than 50% so far in 2019. The nice gain is a welcome change for Scotts, but just…
